FDA inspection

Yangzhou Aurisco Pharmaceutical Co., Ltd.: FDA inspection ending Jun 19, 2026

FDA inspection 1326202 · Yangzhou

Key facts

Inspection ID 1326202
Firm Yangzhou Aurisco Pharmaceutical Co., Ltd.
FEI number 3021695089
Address High-Tech, No. 28 Jianan Road; Industrial Development Zone
City Yangzhou
Fiscal year 2026
Inspection end date Jun 19, 2026
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections